Big news this week on the pharma front: A Doylestown-based provider of clinical trial services called BioClinica was acquired by Cinven, an equity firm out of London.
NEWS: @bioclinica poised for continued growth & innovation under new ownership https://t.co/puxvOpb3M8
— Clario (@Clario) August 23, 2016
The deal, as reported by Reuters earlier this week, puts BioClinica’s valuation at an estimated $1.4 billion, according to sources with knowledge of the negotiations. This move marks BioClinica’s second acquisition, as it was previously bought in 2013 by JLL Partners. In 2014 it merged with a company called CCBR-Synarc Inc., owned by Water Street Healthcare Partners.
“We experienced tremendous growth under our prior ownership and look forward to leveraging the strategic leadership and investment that will come with Cinven,” John Hubbard, BioClinica’s president and CEO, said in a press release. “Bioclinica is on a quest to accelerate and bring clarity to clinical trials, and this move will help us to achieve these goals.”
Sounds like the clinical trials space is alive and well in the Philly area.
Before you go...
Please consider supporting Technical.ly to keep our independent journalism strong. Unlike most business-focused media outlets, we don’t have a paywall. Instead, we count on your personal and organizational support.
3 ways to support our work:- Contribute to the Journalism Fund. Charitable giving ensures our information remains free and accessible for residents to discover workforce programs and entrepreneurship pathways. This includes philanthropic grants and individual tax-deductible donations from readers like you.
- Use our Preferred Partners. Our directory of vetted providers offers high-quality recommendations for services our readers need, and each referral supports our journalism.
- Use our services. If you need entrepreneurs and tech leaders to buy your services, are seeking technologists to hire or want more professionals to know about your ecosystem, Technical.ly has the biggest and most engaged audience in the mid-Atlantic. We help companies tell their stories and answer big questions to meet and serve our community.
Join our growing Slack community
Join 5,000 tech professionals and entrepreneurs in our community Slack today!
The person charged in the UnitedHealthcare CEO shooting had a ton of tech connections
From rejection to innovation: How I built a tool to beat AI hiring algorithms at their own game
Where are the country’s most vibrant tech and startup communities?
